HIGHLIGHTS
- who: Unknown from the Department of Pediatric Hematology and Oncology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Department of Pediatric Oncology, University Hospital for Children and Adolescents, Luebeck, Germany have published the article: Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study, in the Journal: (JOURNAL) of June/11,/2016
- what: For the first aim of the genotype study, a candidate gene approach was applied to validate 10 previously identified single nucleotide polymorphisms (SNPs) associated with hearing loss in childhood cancer patients and survivors : ACYP2, LRP2, NFE2L2, OTOS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.